Anixa Biosciences earnings were -$11.1M for the trailing 12 months ending Jul 31, 2025, with N/A growth year over year. The latest ANIX earnings report on Jul 31, 2025 announced Q3 2025 earnings of -$2.3M, down 19.1% from last quarter. For the last reported fiscal year 2024 ending Oct 31, 2024, ANIX reported annual earnings of -$12.6M, with 28% growth.
What were Anixa Biosciences's earnings last quarter?
Anixa Biosciences (NASDAQ: ANIX) reported Q2 2025 earnings per share (EPS) of -$0.07, up 30% year over year. Total ANIX earnings for the quarter were -$2.26 million. In the same quarter last year, Anixa Biosciences's earnings per share (EPS) was -$0.10.
As of the last Anixa Biosciences earnings report, Anixa Biosciences is currently losing money. Anixa Biosciences's net profit (also called net income) for the twelve months ending Jul 31, 2025 was -$11.12 million, a 10.08% decrease year over year.
What was ANIX's earnings growth in the past year?
As of Anixa Biosciences's earnings date in Q3 2025, Anixa Biosciences's earnings has grown year over year. ANIX earnings in the past year totalled -$11.12 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.